Simultaneous blockade of IL-6 and CCL5 signaling for synergistic inhibition of triple-negative breast cancer growth and metastasis

BACKGROUND: Metastatic triple-negative breast cancer (TNBC) is a heterogeneous and incurable disease. Numerous studies have been conducted to seek molecular targets to treat TNBC effectively, but chemotherapy is still the main choice for patients with TNBC. We have previously presented evidence of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Kideok, Pandey, Niranjan B., Popel, Aleksander S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000947/
https://www.ncbi.nlm.nih.gov/pubmed/29898755
http://dx.doi.org/10.1186/s13058-018-0981-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000947/
https://www.ncbi.nlm.nih.gov/pubmed/29898755
http://dx.doi.org/10.1186/s13058-018-0981-3

Ejemplares similares